FDA Budget Increases For OTC Drugs, Supplements Survive 2004 Process
This article was originally published in The Tan Sheet
Funding increases for OTC drug and dietary supplement activities at FDA are likely to see increased support from the Bush administration and Congress as the fiscal year 2005 budget process kicks off
You may also be interested in...
FDA's fiscal 2005 budget request provides no new increase for over-the-counter drug activities
FDA Commissioner Mark McClellan, MD/PhD, highlighted the cost-effectiveness of OTC drugs in reducing pricing pressures on the healthcare system at an Academy Health/Health Affairs National Health Policy Conference Jan. 28
FDA plans to take a more active role in initiating Rx-to OTC switches in coming years, Senior Associate Commissioner for Management & Systems Jeff Weber said Feb. 3